184 related articles for article (PubMed ID: 23468885)
1. The selective phosphodiesterase 4 inhibitor roflumilast and phosphodiesterase 3/4 inhibitor pumafentrine reduce clinical score and TNF expression in experimental colitis in mice.
Rieder F; Siegmund B; Bundschuh DS; Lehr HA; Endres S; Eigler A
PLoS One; 2013; 8(2):e56867. PubMed ID: 23468885
[TBL] [Abstract][Full Text] [Related]
2. Roflumilast, type 4 phosphodiesterase inhibitor, attenuates inflammation in rats with ulcerative colitis via down-regulation of iNOS and elevation of cAMP.
El-Ashmawy NE; Khedr NF; El-Bahrawy HA; El-Adawy SA
Int Immunopharmacol; 2018 Mar; 56():36-42. PubMed ID: 29331766
[TBL] [Abstract][Full Text] [Related]
3. Adenosine kinase inhibitor GP515 improves experimental colitis in mice.
Siegmund B; Rieder F; Albrich S; Wolf K; Bidlingmaier C; Firestein GS; Boyle D; Lehr HA; Loher F; Hartmann G; Endres S; Eigler A
J Pharmacol Exp Ther; 2001 Jan; 296(1):99-105. PubMed ID: 11123368
[TBL] [Abstract][Full Text] [Related]
4. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
[TBL] [Abstract][Full Text] [Related]
5. The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice.
Loher F; Schmall K; Freytag P; Landauer N; Hallwachs R; Bauer C; Siegmund B; Rieder F; Lehr HA; Dauer M; Kapp JF; Endres S; Eigler A
J Pharmacol Exp Ther; 2003 May; 305(2):549-56. PubMed ID: 12606674
[TBL] [Abstract][Full Text] [Related]
6. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.
Konrad FM; Bury A; Schick MA; Ngamsri KC; Reutershan J
PLoS One; 2015; 10(4):e0121725. PubMed ID: 25909327
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the therapeutic index of a novel phosphodiesterase 4B-selective inhibitor over phosphodiesterase 4D in mice.
Suzuki O; Mizukami K; Etori M; Sogawa Y; Takagi N; Tsuchida H; Morimoto K; Goto T; Yoshino T; Mikkaichi T; Hirahara K; Nakamura S; Maeda H
J Pharmacol Sci; 2013; 123(3):219-26. PubMed ID: 24152964
[TBL] [Abstract][Full Text] [Related]
8. The role of phosphodiesterase 4B in IL-8/LTB4-induced human neutrophil chemotaxis evaluated with a phosphodiesterase 4B inhibitor.
Suzuki O; Goto T; Yoshino T; Nakamura S; Maeda H
Acta Pharm; 2015 Jun; 65(2):191-7. PubMed ID: 26011935
[TBL] [Abstract][Full Text] [Related]
9. Roflumilast, a Phosphodiesterases-4 (PDE4) Inhibitor, Alleviates Sepsis‑induced Acute Kidney Injury.
Xu X; Liao L; Hu B; Jiang H; Tan M
Med Sci Monit; 2020 May; 26():e921319. PubMed ID: 32449901
[TBL] [Abstract][Full Text] [Related]
10. The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer's Disease: A Preclinical Study in APP/PS1 Transgenic Mice.
Wang H; Zhang FF; Xu Y; Fu HR; Wang XD; Wang L; Chen W; Xu XY; Gao YF; Zhang JG; Zhang HT
Int J Neuropsychopharmacol; 2020 Dec; 23(10):700-711. PubMed ID: 32645141
[TBL] [Abstract][Full Text] [Related]
11. The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db/db mice.
Vollert S; Kaessner N; Heuser A; Hanauer G; Dieckmann A; Knaack D; Kley HP; Beume R; Weiss-Haljiti C
Diabetologia; 2012 Oct; 55(10):2779-2788. PubMed ID: 22790061
[TBL] [Abstract][Full Text] [Related]
12. The modulatory effects of the PDE4 inhibitors CHF6001 and roflumilast in alveolar macrophages and lung tissue from COPD patients.
Lea S; Metryka A; Li J; Higham A; Bridgewood C; Villetti G; Civelli M; Facchinetti F; Singh D
Cytokine; 2019 Nov; 123():154739. PubMed ID: 31319374
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
[TBL] [Abstract][Full Text] [Related]
14. Additive anti-inflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells.
Tannheimer SL; Sorensen EA; Haran AC; Mansfield CN; Wright CD; Salmon M
Pulm Pharmacol Ther; 2012 Apr; 25(2):178-84. PubMed ID: 22306235
[TBL] [Abstract][Full Text] [Related]
15. Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes.
Totani L; Amore C; Di Santo A; Dell'Elba G; Piccoli A; Martelli N; Tenor H; Beume R; Evangelista V
J Thromb Haemost; 2016 Jan; 14(1):191-204. PubMed ID: 26484898
[TBL] [Abstract][Full Text] [Related]
16. MnO
Song C; Wu J; Wu J; Wang F
J Nanobiotechnology; 2024 May; 22(1):294. PubMed ID: 38807127
[TBL] [Abstract][Full Text] [Related]
17. Anti-neutrophilic inflammatory activity of ASP3258, a novel phosphodiesterase type 4 inhibitor.
Kubo S; Kobayashi M; Iwata M; Miyata K; Takahashi K; Shimizu Y
Int Immunopharmacol; 2012 Jan; 12(1):59-63. PubMed ID: 22041526
[TBL] [Abstract][Full Text] [Related]
18. Acute treatment with the PDE4 inhibitor roflumilast improves verbal word memory in healthy old individuals: a double-blind placebo-controlled study.
Blokland A; Van Duinen MA; Sambeth A; Heckman PRA; Tsai M; Lahu G; Uz T; Prickaerts J
Neurobiol Aging; 2019 May; 77():37-43. PubMed ID: 30776650
[TBL] [Abstract][Full Text] [Related]
19. Effects of tadalafil (PDE5 inhibitor) and roflumilast (PDE4 inhibitor) on airway reactivity and markers of inflammation in ovalbumin-induced airway hyperresponsiveness in guinea pigs.
Mokry J; Urbanova A; Medvedova I; Kertys M; Mikolka P; Kosutova P; Mokra D
J Physiol Pharmacol; 2017 Oct; 68(5):721-730. PubMed ID: 29375047
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of phosphodiesterase type 4 enhances rat corpus cavernosum nerve-mediated relaxation induced by gasotransmitters.
Fernandes VS; López-Oliva ME; Martínez MP; Agis-Torres Á; Recio P; Navarro-Dorado J; Barahona MV; Benedito S; Prieto D; Climent B; Hernández M
Life Sci; 2022 May; 296():120432. PubMed ID: 35219697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
